Allogeneic hematopoietic stem cell transplantation
Showing 9976 - 10000 of >10,000
Intermittent Claudication, PAD, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No PB-MNC therapy)
Recruiting
- Intermittent Claudication
- +2 more
- PB-MNC therapy
- No PB-MNC therapy
-
Bangkoknoi, Bangkok, ThailandFaculty of Medicine, Siriraj Hospital, Mahidol University
Dec 16, 2021
Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)
Recruiting
- Sickle Cell Disease
- Deferasirox 360 MG
-
Amsterdam, Meibergdreef 9, NetherlandsAmsterdan UMC location AMC
May 23, 2022
Giant Cell Arteritis Trial in Nice
Completed
- Giant Cell Arteritis
-
Nice, Alpes-Maritimes, FranceHospital of the Archet
Jul 20, 2022
End Stage Renal Disease (ESRD) Trial in London (Seacalphyx (sodium thiosulfate pentahydrate injection BP) 25%)
Enrolling by invitation
- End Stage Renal Disease (ESRD)
- Seacalphyx (sodium thiosulfate pentahydrate injection BP) 25%
-
London, Ontario, CanadaLondon Health Sciences Centre, University Hospital
Oct 6, 2021
Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients
Completed
- Cytomegalovirus Infection
- GVHD
-
Regensburg, GermanyUniversitätsklinikum Regensburg
Aug 7, 2018
NSCLC Trial in United States (Nivolumab, Ipilimumab)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Chicago, Illinois
- +11 more
Aug 31, 2022
Leukemia, B-Cell Trial in Houston (Autologous TriCAR T-cells and lymphodepletion chemo)
Not yet recruiting
- Leukemia, B-Cell
- Autologous TriCAR T-cells and lymphodepletion chemotherapy
-
Houston, Texas
- +1 more
Nov 3, 2021
Esophageal Carcinoma, Esophagogastric Junction Carcinoma Trial in China (pembrolizumab, paclitaxel, docetaxel)
Completed
- Esophageal Carcinoma
- Esophagogastric Junction Carcinoma
- pembrolizumab
- +3 more
-
Hefei, Anhui, China
- +22 more
Aug 16, 2022
Kidney Transplant; Complications, Pain, Postoperative Trial in Washington (Intravenous Lidocaine, Transversus abdominis plane
Recruiting
- Kidney Transplant; Complications
- Pain, Postoperative
- Intravenous Lidocaine
- +2 more
-
Washington, District of ColumbiaGeorge Washington University Hospital
Sep 10, 2021
Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant
Recruiting
- Pancreatic Cancer
- +3 more
- Cyclophosphamide
- +3 more
-
Shanghai, ChinaChanghai Hospital
Jun 13, 2022
Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -
Recruiting
- Chronic Myeloid Leukemia in Myeloid Blast Crisis
- +3 more
- based decitabine and olverembatinib(HQP1351)chemotherapy
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022
Rotator Cuff Injuries Trial in Seongnam-si, Seoul (TPX-115, Placebo)
Active, not recruiting
- Rotator Cuff Injuries
- TPX-115
- Placebo
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Jul 22, 2021
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Larotrectinib Sulfate
-
Houston, TexasM D Anderson Cancer Center
Apr 18, 2022
Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory
Active, not recruiting
- Biphasic Mesothelioma
- +9 more
- Pembrolizumab
- +2 more
-
Chicago, IllinoisUniversity of Chicago
Apr 18, 2022
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in Hefei, Nanjing, Beijing (LUCAR-20S CAR-T
Recruiting
- Diffuse Large B Cell Lymphoma
- +3 more
- LUCAR-20S CAR-T cells
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Aug 5, 2021
Using ctDNA to Detect Minimal Residual Disease After Lung Cancer
Recruiting
- Non Small Cell Lung Cancer
-
Toronto, Ontario, Canada
- +2 more
Feb 14, 2022
Head Neck Cancer Trial in Boston (Nivolumab, Ipilimumab, Standard of Care Surgery)
Active, not recruiting
- Head and Neck Cancer
- Nivolumab
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 22, 2022
HIV Trial in Washington (HST-NEETs)
Active, not recruiting
- HIV Infections
- HST-NEETs
-
Washington, District of Columbia
- +2 more
Feb 22, 2022
BCC, BCC - Basal Cell Carcinoma, Basal Cell Carcinoma Trial in New York (drug, procedure, other)
Recruiting
- BCC
- +5 more
- Jet injection of ALA
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 23, 2022
Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint
Not yet recruiting
- Recurrent Head and Neck Cancer
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 30, 2023
Acute Myeloid Leukemia Trial in Columbus (Azacitidine, Biopsy, Enasidenib)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 30, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Cefepime
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2022
Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)
Completed
- Hematologic Malignancies
- RD13-01 cell infusion
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Jan 8, 2022
Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)
Recruiting
- Acute Myeloid Leukemia
- Universal Donor Natural Killer Cells
-
Columbus, OhioNationwide Children's Hospital
Aug 11, 2022
Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)
Recruiting
- Small Cell Lung Cancer Limited Stage
- Durvalumab
- standard of care
-
Löwenstein, Baden-Würtemberg, Germany
- +9 more
May 18, 2022